Development of a Novel EGFR-Targeting Antibody-Drug Conjugate for Pancreatic Cancer Therapy

被引：0
|
作者：
Zhuanglin Li
Mingxue Wang
Xuejing Yao
Wenting Luo
Yaocheng Qu
Deling Yu
Xue Li
Jianmin Fang
Changjiang Huang
机构：
[1] RemeGen,School of Life Science and Technology
[2] Ltd.,undefined
[3] Mabplex International Ltd.,undefined
[4] Tongji University,undefined
来源：
Targeted Oncology | 2019年 / 14卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：93 / 105
页数：12
相关论文
共 50 条
  • [1] Development of a Novel EGFR-Targeting Antibody-Drug Conjugate for Pancreatic Cancer Therapy
    Li, Zhuanglin
    Wang, Mingxue
    Yao, Xuejing
    Luo, Wenting
    Qu, Yaocheng
    Yu, Deling
    Li, Xue
    Fang, Jianmin
    Huang, Changjiang
    [J]. TARGETED ONCOLOGY, 2019, 14 (01) : 93 - 105
  • [2] A Novel c-MET-Targeting Antibody-Drug Conjugate for Pancreatic Cancer
    Jin, Yangbing
    Zhang, Zehui
    Zou, Siyi
    Li, Fanlu
    Chen, Hao
    Peng, Chenghong
    Deng, Xiaxing
    Wen, Chenlei
    Shen, Baiyong
    Zhan, Qian
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [3] Development of novel MUC1-C targeting antibody-drug conjugate for pancreatic cancer treatment
    Ahmad, Rehan
    Panchamoorthy, Govind
    Raina, Deepak
    Lawney, Brian
    Kharbanda, Surender
    Jasuja, Ravi
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [4] Antibody-drug conjugate targeting tissue factor for pancreatic cancer treatment
    Tsumura, Ryo
    Anzai, Takahiro
    Manabe, Shino
    Takashima, Hiroki
    Koga, Yoshikatsu
    Yasunaga, Masahiro
    Matsumura, Yasuhiro
    [J]. CANCER SCIENCE, 2021, 112 : 725 - 725
  • [5] Discovery of A Novel EGFR-Targeting Antibody-Drug Conjugate, SHR-A1307, for the Treatment of Solid Tumors Resistant or Refractory to Anti-EGFR Therapies
    He, Kaijie
    Xu, Jianyan
    Liang, Jindong
    Jiang, Jiahua
    Tang, Mi
    Ye, Xin
    Zhang, Zhebin
    Zhang, Lei
    Fu, Beibei
    Li, Yan
    Bai, Chang
    Zhang, Lianshan
    Tao, Weikang
    [J]. MOLECULAR CANCER THERAPEUTICS, 2019, 18 (06) : 1104 - 1114
  • [6] Preclinical development of a novel antibody-drug conjugate targeting "cold" tumors
    Kaplan, Angelo
    Attanasio, Nickolas
    Do, To Uyen T.
    Swaminathan, Sudha
    Bisht, Arnima
    Lou, San Lin
    Allen, Jason
    Boyd, Robert
    Ackroyd, James E.
    Feldman, Gleb
    Rohlff, Christian
    Dusek, Rachel L.
    [J]. CANCER RESEARCH, 2018, 78 (13)
  • [7] A Traceless Vascular-Targeting Antibody-Drug Conjugate for Cancer Therapy
    Bernardes, Goncalo J. L.
    Casi, Giulio
    Truessel, Sabrina
    Hartmann, Isabelle
    Schwager, Kathrin
    Scheuermann, Joerg
    Neri, Dario
    [J]. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2012, 51 (04) : 941 - 944
  • [8] IMGN289, an EGFR-targeting antibody-drug conjugate, is effective against tumor cells that are resistant to EGFR tyrosine kinase inhibitors
    Setiady, Yulius Y.
    Dong, Ling
    Skaletskaya, Anna
    Pinkas, Jan
    Lutz, Robert J.
    Lambert, John M.
    Chittenden, Thomas
    [J]. CANCER RESEARCH, 2014, 74 (19)
  • [9] A MET Targeting Antibody-Drug Conjugate Overcomes Gemcitabine Resistance in Pancreatic Cancer
    Cazes, Alex
    Betancourt, Oscar
    Esparza, Edgar
    Mose, Evangeline S.
    Jaquish, Dawn
    Wong, Eric
    Wascher, Alexis A.
    Tiriac, Herve
    Gymnopoulos, Marco
    Lowy, Andrew M.
    [J]. CLINICAL CANCER RESEARCH, 2021, 27 (07) : 2100 - 2110
  • [10] Preclinical Development of a Bcma Targeting Antibody-Drug Conjugate with Novel Payload for Multiple Myeloma Therapy
    Hau, Andrew
    Zhu, Tong
    Wang, Rengang
    Lau, Megan
    Li, Lingna
    Li, Xiaoqing
    Sun, Yingqing
    Kovacs, Ernest
    Khasanov, Alisher
    Deng, Dalun
    Yan, Zheng
    Knight, Robert D.
    Kaufmann, Gunnar F.
    Ji, Henry
    Li, Hui
    Zhang, Hong
    [J]. BLOOD, 2019, 134
12345